Related Experiment Video

Updated: Jun 1, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Is cytomegalovirus a therapeutic target in glioblastoma?

John H Sampson1, Duane A Mitchell

  • 1Duke University Medical Center, Durham, North Carolina 27710, USA. john.sampson@duke.edu

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|June 3, 2011
PubMed

Insights

Cytomegalovirus (CMV) genes are found in malignant gliomas, potentially driving cancer growth and immune evasion. Further research is needed to determine if CMV infection levels are sufficient to impact these processes and if CMV can be a therapeutic target.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Malignant gliomas are aggressive brain tumors with complex etiologies.
  • Expression of cytomegalovirus (CMV) genes has been detected in glioma tissues.
  • Some CMV genes are known to influence oncogenesis and immune responses.

Purpose of the Study:

  • To investigate the role of CMV gene expression in malignant gliomas.
  • To assess if CMV infection levels within tumors are sufficient to drive oncogenic or immunosuppressive effects.
  • To explore the potential of CMV as a therapeutic target in glioma treatment.

Main Methods:

  • Analysis of CMV gene expression in glioma samples.
  • Correlation of CMV gene expression levels with tumor characteristics.
  • Assessment of oncogenic and immunosuppressive pathways potentially modulated by CMV.

Main Results:

  • Demonstrated expression of specific CMV genes within malignant gliomas.
  • Identified CMV genes with known roles in oncogenesis and immune modulation.
  • Raised questions about the sufficiency of CMV infection levels to drive key tumor processes.

Conclusions:

  • CMV gene expression is present in malignant gliomas.
  • CMV has the potential to influence glioma oncogenesis and the tumor microenvironment.
  • Further investigation is warranted to confirm CMV's role and therapeutic potential in gliomas.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.